the joint venture , in turn , used the proceeds received from change healthcare inc. to repay $ 805.0 million of its indebtedness under the term loan facility ( as defined herein ) without penalty in july 2019. in march 2020 , mckesson completed a split-off of its interest in the joint venture ( qualified mckesson exit ) through an exchange offer of its common stock for shares of pf2 spinco , inc , a delaware corporation and wholly owned subsidiary of mckesson ( spinco ) . on march 10 , 2020 ( the merger effective date ) , pursuant to the agreement and plan of merger , dated december 20 , 2016 ( the merger agreement ) , by and among change healthcare inc. , mckesson and spinco , change healthcare inc. combined with spinco in a two-step all-stock reverse morris trust transaction that involved ( i ) a separation of spinco from mckesson pursuant to the separation and distribution agreement , dated february 10 , 2020 ( the separation agreement ) , followed by ( ii ) the merger of spinco with and into change healthcare inc. , with change healthcare inc. as the surviving company ( such merger , together with the other transactions contemplated by the merger agreement , the merger ) . the merger was consummated pursuant to the merger agreement and the separation agreement . as a result , the joint venture became a wholly owned subsidiary of change healthcare inc. pursuant to the merger agreement , mckesson accepted 15,426,537 shares of its own common stock , par value $ 0.01 in exchange for all 175,995,192 issued and outstanding shares of spinco common stock , par value $ 0.001 per share ( the spinco common stock ) . all shares of spinco common stock were then converted into an equal number of shares of common stock of change healthcare inc. , par value $ 0.001 , which change healthcare inc. issued to the former holders of spinco common stock , together with cash in lieu of any fractional shares . 75 subsequent to the merger , mckesson no longer holds any equity or voting interest in the joint venture . factors affecting results of operations qualified mckesson exit through the merger , change healthcare inc. acquired the interest in the joint venture that it did not own prior to the transaction . as a result , for the period from march 10 , 2020 to march 31 , 2020 , change healthcare llc was a wholly-owned subsidiary of change healthcare inc. and consolidated the financial position and results of change healthcare llc in its financial statements as of and for the year ended march 31 , 2020. change healthcare inc. accounted for the qualified mckesson exit and related transactions as a business combination achieved in stages in accordance with financial accounting standards board ( fasb ) accounting standards codification ( asc ) 805 , business combinations , resulting in a new basis of accounting . as a result , change healthcare inc. remeasured its investment in the joint venture to fair value as of the date control was obtained and recognized a loss in its statement of operations for the difference in the carrying value and fair value of this investment of approximately $ 230.2 million . further , change healthcare inc. recognized the consideration transferred , as well as the acquired business 's identifiable assets , liabilities and noncontrolling interests at their acquisition date fair value . the excess of the consideration transferred over the fair value of the identifiable assets , liabilities and noncontrolling interest , was recorded as goodwill . as a result of the accounting for these transactions and the change in basis of accounting , the consolidated results of change healthcare inc. in periods following the merger will not be comparable to the consolidated results of the joint venture in periods prior to the merger . the following are certain of the more significant changes resulting from the qualified mckesson exit that will affect the comparability of financial results and operations : increased tangible and intangible assets resulting from adjusting the basis of the assets to their fair value , which will also result in increased depreciation and amortization expense . decrease in long-term debt as a result of adjustments to state the long-term debt at its fair value . decreased deferred revenue as a result of recognizing deferred revenue only to the extent that contractual obligations remain to be fulfilled . these decreases will result in decreased solutions revenue in the near term . income currently attributable to the joint venture and not subject to u.s. federal income taxes and most state and local income taxes will become subject to such taxes , resulting in an increase in change healthcare inc. 's effective tax rate compared with the historical effective tax rate of the joint venture . see note 2 , business combinations for additional information . macroeconomic and industry trends the spread of covid-19 both globally and in the u.s. has driven lower healthcare utilization as a result of the significant reduction in , or in some cases elimination of , elective medical procedures and healthcare visits , without a corresponding increase in covid-19 related transactions . a portion of change healthcare inc. 's business is tied to overall volumes of activity in the healthcare system , and therefore has been adversely impacted by this industry trend . further , weakened economic conditions or a recession could reduce the amounts patients are willing or able to spend on healthcare services . as a result , patients may elect to delay or forgo seeking healthcare services and recent increases in unemployment rates is likely to cause commercial payer membership to decline , which could further reduce healthcare utilization and transaction volumes . story_separator_special_tag see note 11 , long-term debt . ( 3 ) consists of interest payable under the senior credit facilities and senior notes . interest related to the senior credit facilities is based on change healthcare inc. 's interest rates in effect as of march 31 , 2020 and assumes that payments are made in quarterly installments of 1 % of the original principal amount until their maturity . because the interest rates under the senior credit facilities are variable , actual payments may differ . ( 4 ) represents expected amounts due without reduction for any fair value adjustments recognized in prior acquisition method accounting . see note 17 , tax receivable agreements . ( 5 ) represents expected amounts due ; however , the timing and or amount of aggregate payments may vary based on a number of factors , including differences in the expected and actual utilization of prior net operating losses and changes in the tax rate then applicable , whether due to statutory changes or changes in apportionment . see note 17 , tax receivable agreements . 81 ( 6 ) represents expected amounts due ; however , the timing and or amount of aggregate payments may vary based on a number of factors . see note 17 , tax receivable agreements . ( 7 ) represents amounts due under existing operating leases related to change healthcare inc. 's offices and other facilities . see note 19 , commitments . ( 8 ) contingent consideration transferred in connection with acquisitions includes a contingent obligation to make additional payments based on the achievement of certain future performance objectives . because the ultimate timing and amount of payments are dependent on the outcome of future events , the timing and or amount of these additional payments may vary from this estimate . see note 19 , commitments . ( 9 ) represents contractual obligations , including the wipro agreement . see note 19 , commitments . critical accounting estimates the preparation of financial statements in accordance with gaap requires change healthcare inc. to make estimates and assumptions that affect reported amounts and related disclosures . change healthcare inc. considers an accounting estimate to be critical if : it requires assumptions to be made that were uncertain at the time the estimate was made ; and changes in the estimate or different estimates that could have been made could have a material impact on change healthcare inc. 's results of operations and financial condition . see note 3 , significant accounting policies , as well as the critical accounting estimates section for change healthcare llc , for information about other critical accounting policies . equity method investment in the joint venture as disclosed in note 3 , significant accounting policies , change healthcare inc. evaluated its equity method investment for impairment review whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment . if a loss in value occurs that is deemed to be an other-than-temporary impairment ( otti ) , an impairment loss would be recognized . subsequent to its initial public offering , change healthcare inc. had a publicly available indication of the value of its investment in the joint venture . change healthcare inc. considered various factors in determining whether an otti had occurred , including change healthcare inc. 's ability and intent to hold the investment , the trading history available , the implied ebitda valuation multiples compared to public guideline companies , the joint venture 's ability to achieve milestones and any operational and strategic changes by the joint venture that might have negatively impacted the fair value . in the periods prior to the merger , change healthcare inc. determined that an otti had not occurred . goodwill goodwill from change healthcare inc. 's acquisitions is accounted for using the acquisition method of accounting . change healthcare inc. assesses its goodwill for impairment annually ( as of january 1 of each year ) or whenever significant indicators of impairment are present . change healthcare inc. first assesses whether it can reach a more likely than not conclusion that goodwill is not impaired via qualitative analysis alone . to the extent such a conclusion can not be reached based solely on a qualitative assessment , change healthcare inc. , using the assistance of a valuation specialist as appropriate , compares the fair value of each reporting unit to its associated carrying value . change healthcare inc. will generally recognize an impairment charge for the amount , if any , by which the carrying amount of the reporting unit exceeds its fair value . when necessary , change healthcare inc. estimates the fair value of its reporting units using a methodology that considers both income and market approaches . each approach requires the use of certain assumptions . the income approach requires management to exercise judgment in making assumptions regarding the reporting 82 unit 's future income stream , a discount rate and a constant rate of growth after the initial forecast period utilized . these assumptions are subject to change based on business and economic conditions and could materially affect the indicated values of the joint venture 's reporting units . the market approach requires management to exercise judgment in its selection of guideline companies , as well in its selection of the most relevant transaction multiple . guideline companies selected are comparable to change healthcare inc. in terms of product or service offerings , markets and or customers , among other characteristics . see note 9 , goodwill and intangible assets , for further discussion . change healthcare inc. believes the current assumptions and other considerations used to estimate amounts reflected in its financial statements are appropriate . however , if actual experience differs from the assumptions and other considerations used in estimating amounts reflected in change 's financial statements , the resulting changes could have a material adverse effect on

loss on extinguishment of debt loss on extinguishment of debt for the year ended march 31 , 2020 of $ 20.0 million is related to the write-off of unamortized discounts and debt issuance costs associated with debt repayments . other , net other , net primarily represents income the joint venture receives from mckesson and erx network related to transitional and other services that the joint venture provides them following the closing of the transactions in march 2017. income tax provision ( benefit ) the income tax benefit was $ 1.7 million ( effective tax rate of ( 43.5 ) % ) for the year ended march 31 , 2020 as compared to an income tax benefit of $ 4.5 million ( effective tax rate of ( 2.6 ) % ) for the year ended march 31 , 2019. the joint venture 's income taxes and related effective tax rate are routinely affected by it and its subsidiaries ' legal organization . certain of the joint venture 's subsidiaries are organized as limited liability corporations and report income that is distributed to the members where it is subject to income taxes . other subsidiaries are organized as corporations , for which the tax effects are directly reflected in the joint venture 's financial statements . 90 solutions revenue and adjusted ebitda replace_table_token_10_th ( 1 ) as a result of displaying amounts in millions , rounding differences may exist in the table above . ( 2 ) includes intersegment revenues . software and analytics software and analytics revenue increased $ 36.2 million for the year ended march 31 , 2020 as compared with the prior year .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```loss on extinguishment of debt loss on extinguishment of debt for the year ended march 31 , 2020 of $ 20.0 million is related to the write-off of unamortized discounts and debt issuance costs associated with debt repayments . other , net other , net primarily represents income the joint venture receives from mckesson and erx network related to transitional and other services that the joint venture provides them following the closing of the transactions in march 2017. income tax provision ( benefit ) the income tax benefit was $ 1.7 million ( effective tax rate of ( 43.5 ) % ) for the year ended march 31 , 2020 as compared to an income tax benefit of $ 4.5 million ( effective tax rate of ( 2.6 ) % ) for the year ended march 31 , 2019. the joint venture 's income taxes and related effective tax rate are routinely affected by it and its subsidiaries ' legal organization . certain of the joint venture 's subsidiaries are organized as limited liability corporations and report income that is distributed to the members where it is subject to income taxes . other subsidiaries are organized as corporations , for which the tax effects are directly reflected in the joint venture 's financial statements . 90 solutions revenue and adjusted ebitda replace_table_token_10_th ( 1 ) as a result of displaying amounts in millions , rounding differences may exist in the table above . ( 2 ) includes intersegment revenues . software and analytics software and analytics revenue increased $ 36.2 million for the year ended march 31 , 2020 as compared with the prior year .
```    
 Suspicious Activity Report : the joint venture , in turn , used the proceeds received from change healthcare inc. to repay $ 805.0 million of its indebtedness under the term loan facility ( as defined herein ) without penalty in july 2019. in march 2020 , mckesson completed a split-off of its interest in the joint venture ( qualified mckesson exit ) through an exchange offer of its common stock for shares of pf2 spinco , inc , a delaware corporation and wholly owned subsidiary of mckesson ( spinco ) . on march 10 , 2020 ( the merger effective date ) , pursuant to the agreement and plan of merger , dated december 20 , 2016 ( the merger agreement ) , by and among change healthcare inc. , mckesson and spinco , change healthcare inc. combined with spinco in a two-step all-stock reverse morris trust transaction that involved ( i ) a separation of spinco from mckesson pursuant to the separation and distribution agreement , dated february 10 , 2020 ( the separation agreement ) , followed by ( ii ) the merger of spinco with and into change healthcare inc. , with change healthcare inc. as the surviving company ( such merger , together with the other transactions contemplated by the merger agreement , the merger ) . the merger was consummated pursuant to the merger agreement and the separation agreement . as a result , the joint venture became a wholly owned subsidiary of change healthcare inc. pursuant to the merger agreement , mckesson accepted 15,426,537 shares of its own common stock , par value $ 0.01 in exchange for all 175,995,192 issued and outstanding shares of spinco common stock , par value $ 0.001 per share ( the spinco common stock ) . all shares of spinco common stock were then converted into an equal number of shares of common stock of change healthcare inc. , par value $ 0.001 , which change healthcare inc. issued to the former holders of spinco common stock , together with cash in lieu of any fractional shares . 75 subsequent to the merger , mckesson no longer holds any equity or voting interest in the joint venture . factors affecting results of operations qualified mckesson exit through the merger , change healthcare inc. acquired the interest in the joint venture that it did not own prior to the transaction . as a result , for the period from march 10 , 2020 to march 31 , 2020 , change healthcare llc was a wholly-owned subsidiary of change healthcare inc. and consolidated the financial position and results of change healthcare llc in its financial statements as of and for the year ended march 31 , 2020. change healthcare inc. accounted for the qualified mckesson exit and related transactions as a business combination achieved in stages in accordance with financial accounting standards board ( fasb ) accounting standards codification ( asc ) 805 , business combinations , resulting in a new basis of accounting . as a result , change healthcare inc. remeasured its investment in the joint venture to fair value as of the date control was obtained and recognized a loss in its statement of operations for the difference in the carrying value and fair value of this investment of approximately $ 230.2 million . further , change healthcare inc. recognized the consideration transferred , as well as the acquired business 's identifiable assets , liabilities and noncontrolling interests at their acquisition date fair value . the excess of the consideration transferred over the fair value of the identifiable assets , liabilities and noncontrolling interest , was recorded as goodwill . as a result of the accounting for these transactions and the change in basis of accounting , the consolidated results of change healthcare inc. in periods following the merger will not be comparable to the consolidated results of the joint venture in periods prior to the merger . the following are certain of the more significant changes resulting from the qualified mckesson exit that will affect the comparability of financial results and operations : increased tangible and intangible assets resulting from adjusting the basis of the assets to their fair value , which will also result in increased depreciation and amortization expense . decrease in long-term debt as a result of adjustments to state the long-term debt at its fair value . decreased deferred revenue as a result of recognizing deferred revenue only to the extent that contractual obligations remain to be fulfilled . these decreases will result in decreased solutions revenue in the near term . income currently attributable to the joint venture and not subject to u.s. federal income taxes and most state and local income taxes will become subject to such taxes , resulting in an increase in change healthcare inc. 's effective tax rate compared with the historical effective tax rate of the joint venture . see note 2 , business combinations for additional information . macroeconomic and industry trends the spread of covid-19 both globally and in the u.s. has driven lower healthcare utilization as a result of the significant reduction in , or in some cases elimination of , elective medical procedures and healthcare visits , without a corresponding increase in covid-19 related transactions . a portion of change healthcare inc. 's business is tied to overall volumes of activity in the healthcare system , and therefore has been adversely impacted by this industry trend . further , weakened economic conditions or a recession could reduce the amounts patients are willing or able to spend on healthcare services . as a result , patients may elect to delay or forgo seeking healthcare services and recent increases in unemployment rates is likely to cause commercial payer membership to decline , which could further reduce healthcare utilization and transaction volumes . story_separator_special_tag see note 11 , long-term debt . ( 3 ) consists of interest payable under the senior credit facilities and senior notes . interest related to the senior credit facilities is based on change healthcare inc. 's interest rates in effect as of march 31 , 2020 and assumes that payments are made in quarterly installments of 1 % of the original principal amount until their maturity . because the interest rates under the senior credit facilities are variable , actual payments may differ . ( 4 ) represents expected amounts due without reduction for any fair value adjustments recognized in prior acquisition method accounting . see note 17 , tax receivable agreements . ( 5 ) represents expected amounts due ; however , the timing and or amount of aggregate payments may vary based on a number of factors , including differences in the expected and actual utilization of prior net operating losses and changes in the tax rate then applicable , whether due to statutory changes or changes in apportionment . see note 17 , tax receivable agreements . 81 ( 6 ) represents expected amounts due ; however , the timing and or amount of aggregate payments may vary based on a number of factors . see note 17 , tax receivable agreements . ( 7 ) represents amounts due under existing operating leases related to change healthcare inc. 's offices and other facilities . see note 19 , commitments . ( 8 ) contingent consideration transferred in connection with acquisitions includes a contingent obligation to make additional payments based on the achievement of certain future performance objectives . because the ultimate timing and amount of payments are dependent on the outcome of future events , the timing and or amount of these additional payments may vary from this estimate . see note 19 , commitments . ( 9 ) represents contractual obligations , including the wipro agreement . see note 19 , commitments . critical accounting estimates the preparation of financial statements in accordance with gaap requires change healthcare inc. to make estimates and assumptions that affect reported amounts and related disclosures . change healthcare inc. considers an accounting estimate to be critical if : it requires assumptions to be made that were uncertain at the time the estimate was made ; and changes in the estimate or different estimates that could have been made could have a material impact on change healthcare inc. 's results of operations and financial condition . see note 3 , significant accounting policies , as well as the critical accounting estimates section for change healthcare llc , for information about other critical accounting policies . equity method investment in the joint venture as disclosed in note 3 , significant accounting policies , change healthcare inc. evaluated its equity method investment for impairment review whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment . if a loss in value occurs that is deemed to be an other-than-temporary impairment ( otti ) , an impairment loss would be recognized . subsequent to its initial public offering , change healthcare inc. had a publicly available indication of the value of its investment in the joint venture . change healthcare inc. considered various factors in determining whether an otti had occurred , including change healthcare inc. 's ability and intent to hold the investment , the trading history available , the implied ebitda valuation multiples compared to public guideline companies , the joint venture 's ability to achieve milestones and any operational and strategic changes by the joint venture that might have negatively impacted the fair value . in the periods prior to the merger , change healthcare inc. determined that an otti had not occurred . goodwill goodwill from change healthcare inc. 's acquisitions is accounted for using the acquisition method of accounting . change healthcare inc. assesses its goodwill for impairment annually ( as of january 1 of each year ) or whenever significant indicators of impairment are present . change healthcare inc. first assesses whether it can reach a more likely than not conclusion that goodwill is not impaired via qualitative analysis alone . to the extent such a conclusion can not be reached based solely on a qualitative assessment , change healthcare inc. , using the assistance of a valuation specialist as appropriate , compares the fair value of each reporting unit to its associated carrying value . change healthcare inc. will generally recognize an impairment charge for the amount , if any , by which the carrying amount of the reporting unit exceeds its fair value . when necessary , change healthcare inc. estimates the fair value of its reporting units using a methodology that considers both income and market approaches . each approach requires the use of certain assumptions . the income approach requires management to exercise judgment in making assumptions regarding the reporting 82 unit 's future income stream , a discount rate and a constant rate of growth after the initial forecast period utilized . these assumptions are subject to change based on business and economic conditions and could materially affect the indicated values of the joint venture 's reporting units . the market approach requires management to exercise judgment in its selection of guideline companies , as well in its selection of the most relevant transaction multiple . guideline companies selected are comparable to change healthcare inc. in terms of product or service offerings , markets and or customers , among other characteristics . see note 9 , goodwill and intangible assets , for further discussion . change healthcare inc. believes the current assumptions and other considerations used to estimate amounts reflected in its financial statements are appropriate . however , if actual experience differs from the assumptions and other considerations used in estimating amounts reflected in change 's financial statements , the resulting changes could have a material adverse effect on

